Quality Control for 11C and 18F Radiopharmaceuticals in the Research Environment

  • Thomas J. Ruth
  • Salma Jivan
  • Michael J. Adam


There are two general approaches to regulating the production of radiopharmaceuticals. One is based on performance standards and the other is through prescriptive regulations. With performance standards, the general requirements are defined that describe the production and quality control of a radiopharmaceutical. This approach allows for the institution to arrive at a suitable protocol as long as it meets the specified goal of applicability for human use. Thus, a system based on performance standards must have highly trained personnel.


Shelf Life Performance Standard Test Paper Radiochemical Purity Prescriptive Regulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vera-Ruiz, H., Marcus, C.S., Pike, V.W., Coenen, H.H., Fowler, J.S., Meyer, G.J., Cox, P.H., Vaalburg, W., Cantineau, R., Helus, F., and Lambrecht, R.M., 1990, Report of an International Atomic Energy Agency’s Advisory Group Meeting on “Quality Control of Cyclotron-produced Radiopharmaceuticals.”, Nucl. Med. Biol. 17:445–456.Google Scholar
  2. 2.
    Pike, V.W., Waters, S.L., Kensett, M.J., Bateman, D., Considine, D., Turton, D.R., Luthra, S.K., Brady, F., Shah, A., Shah, F., and Silvester, D.J., 1991, Radiopharmaceutical production for PET: Quality assurance practice, experience and issues, in: “New Trends in Radiopharmaceutical Synthesis, Quality Assurance and Regulatory Control,” A.M. Emran, ed. Plenum Press, New York.Google Scholar
  3. 3.
    Ruth, T.J., Adam, M.J., Morris, D., and Jivan, S., 1986, Microprocessor controlled system for automatic and semi-automatic syntheses of radiopharmaceuticals. J. Labelled Compd. Radiopharm. 23:1185–1186.Google Scholar
  4. 4.
    United States Pharmacopeial Convention, 1989, Flu-deoxyglucose F-18 Injection Monograph, in: “United States Pharmacopeia/National Formulary XXI, Suppl. 9” 3190.Google Scholar
  5. 5.
    Adam, M.J. and Jivan, S., 1988, Synthesis and purification of L-6-[18F]fluorodopa, Appl. Radiat. Isot. 39: 1203.CrossRefGoogle Scholar
  6. 6.
    Namavari, M., Bishop, A., Satyamurthy, N., Bida, G., and Barrio, J., 1992, Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa, Appl. Radiat. hot. 43:989–996.CrossRefGoogle Scholar
  7. 7.
    Ehrin, E., Gawell, L., Hogberg, T., de Paulis, T., and Strom, P., 1987, Synthesis of [methoxy-3H]-and [methoxy- C]-labelled raclopride. Specific dopamine D2 receptor ligands, J. Labelled Compd. Radiopharm. 24:931.CrossRefGoogle Scholar
  8. 8.
    Pike, V.W., Kensett, M.J., Turton, D.R., Waters, S.L., and Silvester, D.J., 1990, Labelled agents for PET studies of the dopaminergic system — Some quality assurance methods, experience and issues, Appl. Radiat. hot. 41:483–492.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Thomas J. Ruth
    • 1
  • Salma Jivan
    • 1
  • Michael J. Adam
    • 1
  1. 1.UBC/TRIUMF PET ProgramVancouverCanada

Personalised recommendations